Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to assess the effect of renal impairment on the pharmacokinetics of enpatoran.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For Control Group 1 (Normal Renal Function):
For Group 2 (Impaired Renal Function):
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Central trial contact
Communication Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal